FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948385674> ?p ?o ?g. }

• W2948385674 abstract "Bisphosphonates (BPs) are antiresorptive drugs that act as effective inhibitors of cancer cell proliferation. However, not all bisphosphonates are equally effective against breast cancer cells in vitro. The present study investigated the extent to which three BPs decrease the viability of MCF-7 human breast cancer cells, stimulate cell apoptosis and inhibit cell migration by modulating proteins in the mevalonate pathway. The three BPs exerted direct anticancer effects against MCF-7 cells in a dose- and time-dependent manner, with pamidronate demonstrating the highest efficacy. In addition, the BPs inhibited colony formation ability. The activity of BPs against MCF-7 cells was inhibited by the mevalonate product geranylgeranyl pyrophosphate, which was potentiated by doxorubicin. It was also identified that BPs modulated Ras-related C3 botulinum toxin substrate 1, Ras homolog gene family member A and cell division control protein 42 homolog gene expression. Consistent with the observed growth inhibitory effects, BPs also inhibited the cell cycle by promoting G1 phase arrest and the downregulation of cyclin D1 and upregulation of p21. Additionally, BPs were revealed to induce reactive oxygen species expression, caspase-3 activity and increase the mitochondrial transmembrane potential, which was associated with apoptosis. BP-induced cancer cell apoptosis was detected by acridine orange/ethidium bromide staining and flow cytometry analysis, and was identified to be associated with the induction of caspase-3 and cytochrome c protein expression. Furthermore, BPs significantly decreased cancer cell migration in a dose-dependent manner and reduced matrix metallopeptidase-9 protein expression. In summary, the current study demonstrated that BPs exhibited a direct anticancer effect and an antimigratory effect on MCF-7 cells. These findings suggest that BPs may be developed as a therapeutic option for breast cancer and may serve as sensitizing chemotherapeutic agents." @default.
• W2948385674 created "2019-06-14" @default.
• W2948385674 creator A5045433314 @default.
• W2948385674 creator A5063304502 @default.
• W2948385674 date "2019-06-05" @default.
• W2948385674 modified "2023-09-25" @default.
• W2948385674 title "Antiproliferative and antimigratory activities of bisphosphonates in human breast cancer cell line MCF‑7" @default.
• W2948385674 cites W1519154160 @default.
• W2948385674 cites W1567485746 @default.
• W2948385674 cites W1839381104 @default.
• W2948385674 cites W1862785984 @default.
• W2948385674 cites W1938796902 @default.
• W2948385674 cites W193883077 @default.
• W2948385674 cites W1969385456 @default.
• W2948385674 cites W1978478799 @default.
• W2948385674 cites W1979346765 @default.
• W2948385674 cites W1989014251 @default.
• W2948385674 cites W1991550920 @default.
• W2948385674 cites W2006825597 @default.
• W2948385674 cites W2012141576 @default.
• W2948385674 cites W2029192858 @default.
• W2948385674 cites W2034663338 @default.
• W2948385674 cites W2034901476 @default.
• W2948385674 cites W2035311100 @default.
• W2948385674 cites W2038995854 @default.
• W2948385674 cites W2040874414 @default.
• W2948385674 cites W2041367424 @default.
• W2948385674 cites W2041832326 @default.
• W2948385674 cites W2041868422 @default.
• W2948385674 cites W2051747485 @default.
• W2948385674 cites W2054579240 @default.
• W2948385674 cites W2060630299 @default.
• W2948385674 cites W2071070389 @default.
• W2948385674 cites W2084651782 @default.
• W2948385674 cites W2093164779 @default.
• W2948385674 cites W2104717964 @default.
• W2948385674 cites W2107277218 @default.
• W2948385674 cites W2110466791 @default.
• W2948385674 cites W2113028183 @default.
• W2948385674 cites W2115377499 @default.
• W2948385674 cites W2127069858 @default.
• W2948385674 cites W2136306650 @default.
• W2948385674 cites W2139985739 @default.
• W2948385674 cites W2142553720 @default.
• W2948385674 cites W2151802968 @default.
• W2948385674 cites W2170158378 @default.
• W2948385674 cites W2334011999 @default.
• W2948385674 cites W2337102724 @default.
• W2948385674 cites W2340039096 @default.
• W2948385674 cites W2482902913 @default.
• W2948385674 cites W2527438532 @default.
• W2948385674 cites W1964184380 @default.
• W2948385674 doi "https://doi.org/10.3892/ol.2019.10438" @default.
• W2948385674 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6607035" @default.
• W2948385674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31423185" @default.
• W2948385674 hasPublicationYear "2019" @default.
• W2948385674 type Work @default.
• W2948385674 sameAs 2948385674 @default.
• W2948385674 citedByCount "9" @default.
• W2948385674 countsByYear W29483856742019 @default.
• W2948385674 countsByYear W29483856742020 @default.
• W2948385674 countsByYear W29483856742021 @default.
• W2948385674 countsByYear W29483856742022 @default.
• W2948385674 countsByYear W29483856742023 @default.
• W2948385674 crossrefType "journal-article" @default.
• W2948385674 hasAuthorship W2948385674A5045433314 @default.
• W2948385674 hasAuthorship W2948385674A5063304502 @default.
• W2948385674 hasBestOaLocation W29483856741 @default.
• W2948385674 hasConcept C109541995 @default.
• W2948385674 hasConcept C121608353 @default.
• W2948385674 hasConcept C185592680 @default.
• W2948385674 hasConcept C190283241 @default.
• W2948385674 hasConcept C29537977 @default.
• W2948385674 hasConcept C2994423619 @default.
• W2948385674 hasConcept C502942594 @default.
• W2948385674 hasConcept C53227056 @default.
• W2948385674 hasConcept C54355233 @default.
• W2948385674 hasConcept C55493867 @default.
• W2948385674 hasConcept C62112901 @default.
• W2948385674 hasConcept C86803240 @default.
• W2948385674 hasConcept C95444343 @default.
• W2948385674 hasConcept C96232424 @default.
• W2948385674 hasConceptScore W2948385674C109541995 @default.
• W2948385674 hasConceptScore W2948385674C121608353 @default.
• W2948385674 hasConceptScore W2948385674C185592680 @default.
• W2948385674 hasConceptScore W2948385674C190283241 @default.
• W2948385674 hasConceptScore W2948385674C29537977 @default.
• W2948385674 hasConceptScore W2948385674C2994423619 @default.
• W2948385674 hasConceptScore W2948385674C502942594 @default.
• W2948385674 hasConceptScore W2948385674C53227056 @default.
• W2948385674 hasConceptScore W2948385674C54355233 @default.
• W2948385674 hasConceptScore W2948385674C55493867 @default.
• W2948385674 hasConceptScore W2948385674C62112901 @default.
• W2948385674 hasConceptScore W2948385674C86803240 @default.
• W2948385674 hasConceptScore W2948385674C95444343 @default.
• W2948385674 hasConceptScore W2948385674C96232424 @default.
• W2948385674 hasLocation W29483856741 @default.
• W2948385674 hasLocation W29483856742 @default.
• W2948385674 hasLocation W29483856743 @default.
• W2948385674 hasLocation W29483856744 @default.

• next